Correction: MiR-509-3p is clinically significant and strongly attenuates cellular migration and multi-cellular spheroids in ovarian cancer: [Oncotarget., 7, 18, (2016) (25930-25948)] DOI: 10.18632/oncotarget.8412

Yinghong Pan; Gordon Robertson; Lykke Pedersen; Emilia Lim; Anadulce Hernandez-Herrera; Amy C. Rowat; Sagar L. Patil; Clara K. Chan; Yunfei Wen; Xinna Zhang; Upal Basu-Roy; Alka Mansukhani; Andy Chu; Payal Sipahimalani; Reanne Bowlby; Denise Brooks; Nina Thiessen; Cristian Coarfa; Yussanne Ma; Richard A. Moore; Jacquie E. Schein; Andrew J. Mungall; Jinsong Liu; Chad V. Pecot; Anil K. Sood; Steven J.M. Jones; Marco A. Marra; Preethi H. Gunaratne

doi:10.18632/oncotarget.15921

Correction: MiR-509-3p is clinically significant and strongly attenuates cellular migration and multi-cellular spheroids in ovarian cancer: [Oncotarget., 7, 18, (2016) (25930-25948)] DOI: 10.18632/oncotarget.8412

Yinghong Pan, Gordon Robertson, Lykke Pedersen, Emilia Lim, Anadulce Hernandez-Herrera, Amy C. Rowat, Sagar L. Patil, Clara K. Chan, Yunfei Wen, Xinna Zhang, Upal Basu-Roy, Alka Mansukhani, Andy Chu, Payal Sipahimalani, Reanne Bowlby, Denise Brooks, Nina Thiessen, Cristian Coarfa, Yussanne Ma, Richard A. MooreJacquie E. Schein, Andrew J. Mungall, Jinsong Liu, Chad V. Pecot, Anil K. Sood, Steven J.M. Jones, Marco A. Marra, Preethi H. Gunaratne

Research output: Contribution to journal › Comment/debate › peer-review

5 Scopus citations

Original language	English (US)
Pages (from-to)	17406
Number of pages	1
Journal	Oncotarget
Volume	8
Issue number	10
DOIs	https://doi.org/10.18632/oncotarget.15921
State	Published - 2017

ASJC Scopus subject areas

Oncology

Access to Document

10.18632/oncotarget.15921

Cite this

Pan, Y., Robertson, G., Pedersen, L., Lim, E., Hernandez-Herrera, A., Rowat, A. C., Patil, S. L., Chan, C. K., Wen, Y., Zhang, X., Basu-Roy, U., Mansukhani, A., Chu, A., Sipahimalani, P., Bowlby, R., Brooks, D., Thiessen, N., Coarfa, C., Ma, Y., ... Gunaratne, P. H. (2017). Correction: MiR-509-3p is clinically significant and strongly attenuates cellular migration and multi-cellular spheroids in ovarian cancer: [Oncotarget., 7, 18, (2016) (25930-25948)] DOI: 10.18632/oncotarget.8412. Oncotarget, 8(10), 17406. https://doi.org/10.18632/oncotarget.15921

Correction: MiR-509-3p is clinically significant and strongly attenuates cellular migration and multi-cellular spheroids in ovarian cancer: [Oncotarget., 7, 18, (2016) (25930-25948)] DOI: 10.18632/oncotarget.8412. / Pan, Yinghong; Robertson, Gordon; Pedersen, Lykke et al.
In: Oncotarget, Vol. 8, No. 10, 2017, p. 17406.

Research output: Contribution to journal › Comment/debate › peer-review

Pan, Y, Robertson, G, Pedersen, L, Lim, E, Hernandez-Herrera, A, Rowat, AC, Patil, SL, Chan, CK, Wen, Y, Zhang, X, Basu-Roy, U, Mansukhani, A, Chu, A, Sipahimalani, P, Bowlby, R, Brooks, D, Thiessen, N, Coarfa, C, Ma, Y, Moore, RA, Schein, JE, Mungall, AJ, Liu, J, Pecot, CV, Sood, AK, Jones, SJM, Marra, MA & Gunaratne, PH 2017, 'Correction: MiR-509-3p is clinically significant and strongly attenuates cellular migration and multi-cellular spheroids in ovarian cancer: [Oncotarget., 7, 18, (2016) (25930-25948)] DOI: 10.18632/oncotarget.8412', Oncotarget, vol. 8, no. 10, pp. 17406. https://doi.org/10.18632/oncotarget.15921

@article{1a8faced66a94bf7b8bd2ee55d6bfe41,

title = "Correction: MiR-509-3p is clinically significant and strongly attenuates cellular migration and multi-cellular spheroids in ovarian cancer: [Oncotarget., 7, 18, (2016) (25930-25948)] DOI: 10.18632/oncotarget.8412",

author = "Yinghong Pan and Gordon Robertson and Lykke Pedersen and Emilia Lim and Anadulce Hernandez-Herrera and Rowat, {Amy C.} and Patil, {Sagar L.} and Chan, {Clara K.} and Yunfei Wen and Xinna Zhang and Upal Basu-Roy and Alka Mansukhani and Andy Chu and Payal Sipahimalani and Reanne Bowlby and Denise Brooks and Nina Thiessen and Cristian Coarfa and Yussanne Ma and Moore, {Richard A.} and Schein, {Jacquie E.} and Mungall, {Andrew J.} and Jinsong Liu and Pecot, {Chad V.} and Sood, {Anil K.} and Jones, {Steven J.M.} and Marra, {Marco A.} and Gunaratne, {Preethi H.}",

year = "2017",

doi = "10.18632/oncotarget.15921",

language = "English (US)",

volume = "8",

pages = "17406",

journal = "Oncotarget",

issn = "1949-2553",

publisher = "Impact Journals",

number = "10",

}

TY - JOUR

T1 - Correction

T2 - MiR-509-3p is clinically significant and strongly attenuates cellular migration and multi-cellular spheroids in ovarian cancer: [Oncotarget., 7, 18, (2016) (25930-25948)] DOI: 10.18632/oncotarget.8412

AU - Pan, Yinghong

AU - Robertson, Gordon

AU - Pedersen, Lykke

AU - Lim, Emilia

AU - Hernandez-Herrera, Anadulce

AU - Rowat, Amy C.

AU - Patil, Sagar L.

AU - Chan, Clara K.

AU - Wen, Yunfei

AU - Zhang, Xinna

AU - Basu-Roy, Upal

AU - Mansukhani, Alka

AU - Chu, Andy

AU - Sipahimalani, Payal

AU - Bowlby, Reanne

AU - Brooks, Denise

AU - Thiessen, Nina

AU - Coarfa, Cristian

AU - Ma, Yussanne

AU - Moore, Richard A.

AU - Schein, Jacquie E.

AU - Mungall, Andrew J.

AU - Liu, Jinsong

AU - Pecot, Chad V.

AU - Sood, Anil K.

AU - Jones, Steven J.M.

AU - Marra, Marco A.

AU - Gunaratne, Preethi H.

PY - 2017

Y1 - 2017

UR - http://www.scopus.com/inward/record.url?scp=85014652618&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85014652618&partnerID=8YFLogxK

U2 - 10.18632/oncotarget.15921

DO - 10.18632/oncotarget.15921

M3 - Comment/debate

C2 - 28403581

AN - SCOPUS:85014652618

SN - 1949-2553

VL - 8

SP - 17406

JO - Oncotarget

JF - Oncotarget

IS - 10

ER -

Correction: MiR-509-3p is clinically significant and strongly attenuates cellular migration and multi-cellular spheroids in ovarian cancer: [Oncotarget., 7, 18, (2016) (25930-25948)] DOI: 10.18632/oncotarget.8412

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this